Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Malaria Consortium US Donate
  • About us
    • Who we are
    • Our Strategy
    • Governance
    • Aid transparency
  • Projects
  • Where We Work
  • What we do
    • Diseases
    • Our responses
    • Burden reduction to elimination
    • Data-informed decision-making & digital approaches
    • Health sector resilience
    • Research & policy change
    • Networks & partnerships
  • News & Resources
    • News
    • Blog
    • Videos
    • Webinars
    • Photo stories
  • Publications
    • Interactive publications
  • Support us
  • Contact Us
    • Newsletter
  • Work with us
    • Tenders
  • Home
  • »
  • Publications
  • »
  • A non-randomised controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

Share this page

Resources

Latest

Publications

Publication Date:
03/11/2022

Author:
Anthony Nuwa

Type:
Presentation
Publication

A non-randomised controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

Publication Date:
03/11/2022
Author:
Anthony Nuwa
Type:
Presentation

Malaria is major public health problem in Uganda, affecting almost 100 percent of the population. The National Malaria Control Division and Malaria Consortium conducted a seasonal malaria chemoprevention (SMC) implementation study in Karamoja, where parasite resistance is assumed to be high. Results indicated children in intervention districts had a 92.2 percent lower risk of developing confirmed malaria in the five-month follow-up versus those in the control district.

This presentation was given at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.

Click here to download

Country: Uganda

Keywords: Research | Malaria | Seasonal malaria chemoprevention | SDG3

 

 

« Back to Publications

Sign up for our newsletter here:

Follow us on our social channels
  • Jobs
  • Contact us
  • Annual reviews
  • Support us
  • About us
  • Sitemap
  • Policies
  • Modern Slavery Statement
Fundraising Regulator logo
© 2023 Malaria Consortium | Charity No. 1099776 | Company No. 4785712